MI Sign Up for eTOC Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mansuy, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mansuy, I. M.
Molecular Interventions 2:282-284 (2002)
© 2002 American Society of Pharmacology and Experimental Therapeutics



Viewpoint

STEPping into Position: A New Player in the NMDA Receptor Game

Isabelle M. Mansuy

Institute of Cell Biology, Department of Biology Swiss Federal Institute of Technology (ETH) Hönggerberg, CH-8093 Zürich Switzerland

SUMMARY

The posttranslational modification of proteins—phosphorylation or dephosphorylation of serine and threonine residues—is usually considered essential for the initiation and maintenance of long-term potentiation (LTP) and long-term depression (LTD) in neural plasticity. Pelkey et al. have identified at the N-methyl-D-aspartate (NMDA) receptor a protein tyrosine phosphatase—a member of the striatal-enriched phosphatase family, termed STEP61—that appears to antagonize the effects of Src-mediated tyrosine phosphorylation during the facilitation of LTP. Mansuy reviews the findings of STEP61 as a participant in modulating NMDA receptor-associated plasticity and discusses how differing populations of serine, threonine, and tyrosine phosphorylated or dephosphorylated residues might finely tune plasticity.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.